Clearmind Medicine (CMND) Competitors $1.12 +0.15 (+15.46%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.05 -0.07 (-6.25%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. LPTX, LSB, BFRG, BIVI, MIRA, GLYC, NRSN, ALLR, SLGL, and BCTXShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include Leap Therapeutics (LPTX), Lakeshore Biopharma (LSB), Bullfrog AI (BFRG), BioVie (BIVI), MIRA Pharmaceuticals (MIRA), GlycoMimetics (GLYC), NeuroSense Therapeutics (NRSN), Allarity Therapeutics (ALLR), Sol-Gel Technologies (SLGL), and BriaCell Therapeutics (BCTX). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Leap Therapeutics Lakeshore Biopharma Bullfrog AI BioVie MIRA Pharmaceuticals GlycoMimetics NeuroSense Therapeutics Allarity Therapeutics Sol-Gel Technologies BriaCell Therapeutics Clearmind Medicine (NASDAQ:CMND) and Leap Therapeutics (NASDAQ:LPTX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking. Does the MarketBeat Community prefer CMND or LPTX? Leap Therapeutics received 294 more outperform votes than Clearmind Medicine when rated by MarketBeat users. CompanyUnderperformOutperformClearmind MedicineN/AN/ALeap TherapeuticsOutperform Votes29468.37% Underperform Votes13631.63% Do analysts prefer CMND or LPTX? Leap Therapeutics has a consensus target price of $4.92, indicating a potential upside of 1,252.96%. Given Leap Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Leap Therapeutics is more favorable than Clearmind Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Leap Therapeutics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is CMND or LPTX more profitable? Leap Therapeutics' return on equity of -116.24% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Clearmind MedicineN/A -129.21% -61.15% Leap Therapeutics N/A -116.24%-93.18% Do insiders and institutionals hold more shares of CMND or LPTX? 96.1% of Clearmind Medicine shares are owned by institutional investors. Comparatively, 30.5% of Leap Therapeutics shares are owned by institutional investors. 5.4% of Leap Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to CMND or LPTX? In the previous week, Clearmind Medicine had 4 more articles in the media than Leap Therapeutics. MarketBeat recorded 6 mentions for Clearmind Medicine and 2 mentions for Leap Therapeutics. Clearmind Medicine's average media sentiment score of 0.30 beat Leap Therapeutics' score of -0.50 indicating that Clearmind Medicine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearmind Medicine 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Leap Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Which has higher valuation & earnings, CMND or LPTX? Clearmind Medicine is trading at a lower price-to-earnings ratio than Leap Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearmind MedicineN/AN/A-$5.26M-$1.22-0.92Leap TherapeuticsN/AN/A-$81.41M-$1.84-0.20 Which has more risk and volatility, CMND or LPTX? Clearmind Medicine has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Leap Therapeutics has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500. SummaryClearmind Medicine and Leap Therapeutics tied by winning 7 of the 14 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.78M$6.46B$5.31B$7.35BDividend YieldN/A3.20%5.45%4.29%P/E Ratio-0.606.9521.9417.82Price / SalesN/A231.03380.9597.68Price / CashN/A65.6738.2634.64Price / Book1.535.936.453.98Net Income-$5.26M$143.22M$3.22B$247.81M1 Month Performance-3.46%-13.56%-9.76%-7.91%1 Year Performance-5.49%-8.89%11.49%1.53% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine0.7053 of 5 stars$1.12+15.5%N/A-4.9%$4.78MN/A-0.60N/ANews CoverageGap UpHigh Trading VolumeLPTXLeap Therapeutics1.5425 of 5 stars$0.37+9.8%$4.92+1,213.6%-87.7%$15.44MN/A-0.1940Short Interest ↑Gap DownLSBLakeshore Biopharma0.499 of 5 stars$1.65-6.3%N/AN/A$15.36M$672.27M0.00773Short Interest ↑Gap UpBFRGBullfrog AI0.608 of 5 stars$1.61-10.1%N/A-45.0%$15.16M$60,000.00-1.894Short Interest ↑News CoverageBIVIBioVie1.3784 of 5 stars$0.82-5.0%$3.00+265.4%+72.2%$15.15MN/A-0.0810MIRAMIRA Pharmaceuticals2.7103 of 5 stars$0.90+0.8%$14.00+1,460.4%+8.5%$15.09MN/A-1.602Short Interest ↓News CoverageGap DownGLYCGlycoMimetics1.725 of 5 stars$0.23+2.6%N/A-89.7%$14.70M$10,000.000.0050Analyst ForecastNews CoverageNRSNNeuroSense Therapeutics0.371 of 5 stars$1.06-1.9%N/A-32.0%$14.49MN/A-1.6610Short Interest ↑ALLRAllarity Therapeutics0.2349 of 5 stars$0.84+17.4%N/A-98.0%$14.32MN/A0.0010Short Interest ↑SLGLSol-Gel Technologies1.986 of 5 stars$0.50+16.7%$5.00+900.0%-41.8%$13.93M$11.71M-1.4750News CoverageGap UpBCTXBriaCell Therapeutics1.4037 of 5 stars$3.75-14.4%$32.00+753.3%-86.6%$13.91MN/A-0.288News CoverageGap Down Related Companies and Tools Related Companies LPTX Competitors LSB Competitors BFRG Competitors BIVI Competitors MIRA Competitors GLYC Competitors NRSN Competitors ALLR Competitors SLGL Competitors BCTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
